Home management of oral anticoagulation via telemedicine versus conventional hospital-based treatment

Telemedicine and e-Health

Volumn 17, Issue 3, 2011, Pages 169-176

  Christensen, Henry ^a   Lauterlein, Jens Jacob ^a   Sørensen, Patricia D ^a   Petersen, Eva R B ^a   Madsen, Jonna S ^a,b   Brandslund, Ivan ^a,b  

^a LILLEBAELT HOSPITAL   (Denmark)

^b UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

Author keywords

INR; oral anticoagulation; telemedicine

Indexed keywords

ANTI-COAGULATION; ANTICOAGULATION THERAPY; CONTROLLED TRIAL; CONVENTIONAL COMPUTERS; CONVENTIONAL TREATMENTS; DOSE ADJUSTMENTS; HOME MANAGEMENT; INR; INTERNATIONAL NORMALIZED RATIOS; INTERNET ACCESS; INTERNET-BASED SYSTEMS; ORAL ANTICOAGULATION; THERAPEUTIC RANGE;

COMPUTER CONTROL SYSTEMS; INTERNET; MEDICAL COMPUTING; TELEMEDICINE;

PATIENT TREATMENT;

ANTICOAGULANT AGENT;

ADULT; AGED; ARTICLE; BLOOD; CLINICAL TRIAL; COMPUTER INTERFACE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG MONITORING; FEMALE; HUMAN; INSTRUMENTATION; INTERNATIONAL NORMALIZED RATIO; MALE; METHODOLOGY; MICROCOMPUTER; MIDDLE AGED; PATIENT EDUCATION; RANDOMIZED CONTROLLED TRIAL; TELEMEDICINE;

ADULT; AGED; AGED, 80 AND OVER; ANTICOAGULANTS; DRUG MONITORING; FEMALE; HUMANS; INTERNATIONAL NORMALIZED RATIO; MALE; MICROCOMPUTERS; MIDDLE AGED; PATIENT EDUCATION AS TOPIC; TELEMEDICINE; USER-COMPUTER INTERFACE; YOUNG ADULT;

EID: 79955077903     PISSN: 15305627     EISSN: 15563669     Source Type: Journal    
DOI: 10.1089/tmj.2010.0128     Document Type: Article

References (19)

1. Wurster M, Doran T. Anticoagulation management: A new approach. Disease Manag 2006;9:201-209. (Pubitemid 44784544)
2. The Danish Society of Cardiology. Antitrombotisk behandling ved kardiovaskulære sygdomme "Trombokardiologi" DCS vejledning 2007. Nr. 2. Available at www.dskb.dk/media/documents/dcs.pdf (last accessed April 9, 2010).
3. Miyasaka Y, Barnes ME, Gersh BJ, Cha SS, Bailey KR, Abhayaratna WP, et al. Secular trends in incidence of atrial fibrillation in Olmsted County, Minnesota, 1980 to 2000, and implications on the projections for future prevalence. Circulation 2006;114:119-125. (Pubitemid 44420743)
4. Brandslund I. Development and implementation of an electronic decision support system for oral anticoagulation. Klinisk Biokemi i Norden. 2004;16: 12-15. Available at www.kkno.org/hefter2004/kkn2004-3.pdf (last accessed April 9, 2010).
5. Danish National IT and Telecom Agency. Available at http://en.itst.dk/ (last accessed April 9, 2010).
6. Rosendaal FR, Cannegieter SC, van der Meer FJM, Briët E. A method to determine the optimal intensity of oral anticoagulant therapy. Thromb Haemost 1993;69:236-239. (Pubitemid 23069000)
7. Ryan F, Byrne S, O'Shea S. Randomized controlled trial of supervised self-testing of warfarin therapy using an Internet-based expert system. J Thromb Haemost 2009;7:1284-1290.
8. Schulman S, Kearon C, Kakkar AK, Mismetti P, Schellong S, Eriksson H, et al. Dabigatran versus warfarin in the treatment of acute venous thromboembolism. N Engl J Med 2009;361:2342-2352.
9. Van Walraven C, Oake N, Wells PS, Forster AJ. Burden of potentially avoidable anticoagulant-associated hemorrhagic and thromboembolic events in the elderly. Chest 2007;131:1508-1515. (Pubitemid 46762360)
10. Ryan F, O'Shea S, Byrne S. The reliability of point-of-care prothrombin time testing. A comparison of CoaguChek S and XS INR measurements with hospital laboratory monitoring. Int J Lab Hematol 2010;32:e26-e33.
11. Braun S, Watzke H, Hasenkam JM, Schwab M, Wolf T, Dovifat C, Völler H. Performance evaluation of the new CoaguChek XS system compared with the established CoaguChek system by patients experienced in INR-self management. Thromb Haemost 2007;97:310-314. (Pubitemid 46592153)
12. Wieloch M, Hillarp A, Strandberg K, Nilsson C, Svensson PJ. Comparison and evaluation of a Point-of-care device (CoaguChek XS) to Owren-type prothrombin time assay for monitoring of oral anticoagulant therapy with warfarin. Thromb Res 2009;124:344-348.
13. Plesch W, Van den Besselaar AMHP. Validation of the international normalized ratio (INR) in a new point-of-care system designed for home monitoring of oral anticoagulation therapy. Int J Lab Hematol 2009;31:20-25.
14. Plesch W, Wolf T, Breienbeck N, Dikkeschei LD, Cervero A, Perez PL, Van den Besselaar AMHP. Results of the performance verification of the CoaguChek XS System. Thromb Res 2008;123:381-389.
15. Lassen JF, Brandslund I, Antonsen S. International normalized ratio for prothrombin times in patients taking oral anticoagulants: Critical difference and probability of significant change in consecutive measurements. Clin Chem 1995;41:444-447.
16. Lassen JF, Kjeldsen J, Antonsen S, Petersen PH, Brandslund I. Interpretation of serial measurements of international normalized ratio for prothrombin times in monitoring oral anticoagulant therapy. Clin Chem 1995;41: 1171-1176.
17. Hamad MAS, van Eeklen E, van Agt T, van Straten AHM. Self-management program improves anticoagulation control and quality of life: A prospective randomized study. Eur J Cardiothorac Surg 2009;35:265-269.
18. Jensen CF, Christensen TD, Maegaard M, Hasenkam JM. Quality of anticoagulant therapy in patients who perform self management: Warfarin versus phenoprocoumon. J Thromb Thrombolysis 2009;28:276-281.
19. Fitzmaurice DA, Murray ET, Allan TF, Hobbs FDR. A randomised controlled trial of patient self management of oral anticoagulation treatment compared with primary care management. J Clin Pathol 2002;55:845-849. (Pubitemid 35316252)